Cancer despite immunosurveillance: immunoselection and immunosubversion
نویسندگان
چکیده
منابع مشابه
The Tumor/Immune Interface: Clinical Evidence of Cancer Immunosurveillance, Immunoediting and Immunosubversion
Problem statement: The interactions of a malignant tumor with the patient’s immune system are dynamic, multiple and bi-directional. Approach: This article reviews the clinical evidence of the interaction of cancer with immunity with emphasis on recent developments highlighting some of the mechanisms of tumor-mediated regulation of immunity. Results: Most of the time, the immune response to a ma...
متن کاملImmunosurveillance against cancer-associated hyperploidy
At odds with long-standing convictions, it is now clear that tumors are not immunologically silent entities. We have recently demonstrated that the immune system can selectively detect and eliminate hyperploid (pre-) malignant cells, thus delineating a novel mechanism of immunosurveillance against tumorigenesis. Malignant cells of different histological origin share a set of common features, in...
متن کاملThe immunobiology of cancer immunosurveillance and immunoediting.
The last fifteen years have seen a reemergence of interest in cancer immunosurveillance and a broadening of this concept into one termed cancer immunoediting. The latter, supported by strong experimental data derived from murine tumor models and provocative correlative data obtained by studying human cancer, holds that the immune system not only protects the host against development of primary ...
متن کاملOn immunosurveillance in human cancer.
The extraordinarily high incidence of cancers of many different varieties--carcinomas and lymphomas--in organ-transplant patients being maintained for long periods of time with immunosuppressive drugs is briefly reviewed. The role of immunosurveillance as a primary defense mechanism against cancer in human beings is consistent with these observations and is in need of further investigation. Con...
متن کاملCytokines reinstate NK cell-mediated cancer immunosurveillance.
In healthy individuals, cells that lose expression of MHC class I molecules are quickly targeted for elimination by NK lymphocytes. A paradox in cancer immunology is the observation that many tumor cells often have a drastic reduction of MHC class I molecules, yet these cells are not eliminated by NK cells, as they should be. In this issue of the JCI, Ardolino et al. demonstrate that NK cells t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Immunology
سال: 2006
ISSN: 1474-1733,1474-1741
DOI: 10.1038/nri1936